Metagenomi, Inc. Common Stock / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €8.63M +0.0% -€145.78M -0.6% -1,690.0% +0.10 pp N/A N/A
    (estimated) €8.63M +0.0% -€146.64M +4.6% -1,700.0% -0.75 pp N/A N/A
    (estimated) €8.63M -64.2% -€140.17M +44.3% -1,625.0% -12 pp N/A N/A
    (estimated) €24.13M -1.1% -€97.15M +25.3% -402.7% -0.85 pp -€73.84M +26.0% -306.0% -0.66 pp
    (estimated) €24.40M -45.9% -€77.52M +15.1% -317.7% -1.7 pp -€58.59M -35.9% -240.1% -0.37 pp
    €45.11M +16.8% -€67.33M +14.4% -149.3% +0.032 pp -€91.40M +29.9% -202.6% -0.20 pp
    €38.61M +160.2% -€58.88M +56.6% -152.5% +1.0 pp -€70.38M -286.7% -182.3% -4.4 pp
    €14.84M +6,978.2% -€37.60M +103.3% -253.4% +86 pp €37.70M +60.9% 254.1% -110 pp
    €209.61K -€18.50M -8,823.9% €23.43M 11,177.0%

    Notifications